The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1310 - 1320
In a pooled analysis of data from nearly 250,000 people from 52 studies, the authors estimated the incremental value of C-reactive protein or fibrinogen level...
RISK PROFILE | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | INFLAMMATION | GUIDELINES | CORONARY-HEART-DISEASE | ASSOCIATION | PRIMARY PREVENTION | CARE | Prognosis | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Biomarkers - blood | C-Reactive Protein - metabolism | Mass Screening | Lipids - blood | Fibrinogen - metabolism | Cardiovascular Diseases - blood | Adult | Female | Cohort Studies | Practice Guidelines as Topic | Care and treatment | C-reactive protein | Fibrinogen | Diagnosis | Cardiovascular diseases | Health aspects | Risk factors | Heart attacks | Diabetes mellitus | Data processing | Cardiovascular disease | Reclassification | Cholesterol | Biomarkers | Blood pressure | Smoking | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | cost-effectiveness | metaanalysis | practice guidelines | inflammation | nonvascular mortality | primary prevention | coronary-heart-disease | association | risk profile | statin therapy
RISK PROFILE | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | INFLAMMATION | GUIDELINES | CORONARY-HEART-DISEASE | ASSOCIATION | PRIMARY PREVENTION | CARE | Prognosis | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Biomarkers - blood | C-Reactive Protein - metabolism | Mass Screening | Lipids - blood | Fibrinogen - metabolism | Cardiovascular Diseases - blood | Adult | Female | Cohort Studies | Practice Guidelines as Topic | Care and treatment | C-reactive protein | Fibrinogen | Diagnosis | Cardiovascular diseases | Health aspects | Risk factors | Heart attacks | Diabetes mellitus | Data processing | Cardiovascular disease | Reclassification | Cholesterol | Biomarkers | Blood pressure | Smoking | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | cost-effectiveness | metaanalysis | practice guidelines | inflammation | nonvascular mortality | primary prevention | coronary-heart-disease | association | risk profile | statin therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9709, pp. 132 - 140
Summary Background Associations of C-reactive protein (CRP) concentration with risk of major diseases can best be assessed by long-term prospective follow-up...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | PLASMA-FIBRINOGEN | REGRESSION DILUTION | INFLAMMATION | CARDIOVASCULAR-DISEASE | PROSPECTIVE COHORTS | LOW-DENSITY LIPOPROTEIN | NONVASCULAR MORTALITY | MENDELIAN RANDOMIZATION | VASCULAR-DISEASE | Blood Pressure | Diabetes Mellitus - blood | Cholesterol - blood | Humans | Middle Aged | Lung Diseases - mortality | Male | Motor Activity | Coronary Disease - mortality | Neoplasms - blood | Lung Diseases - blood | Interleukin-6 - blood | Female | Leukocyte Count | Stroke - mortality | C-Reactive Protein - analysis | Databases, Factual | Body Mass Index | Coronary Disease - blood | Stroke - prevention & control | Risk Assessment | Smoking - blood | Risk Factors | Neoplasms - mortality | Biomarkers - blood | Stroke - blood | Regression Analysis | Coronary Disease - prevention & control | Serum Albumin | Alcohol Drinking - blood | Alcohol Drinking - epidemiology | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Fibrinogen - analysis | Sex Factors | Triglycerides - blood | Proteins | Mortality | Cardiovascular disease | Statistical methods | Blood pressure | Risk factors | Statins | Inflammatory diseases | Meta-analysis | Clinical Medicine | Kirurgisk forskning | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Surgical research | Klinisk medicin | MEDICINE | Kirurgi | Ortopedi | Orthopaedics
Internal Medicine | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | PLASMA-FIBRINOGEN | REGRESSION DILUTION | INFLAMMATION | CARDIOVASCULAR-DISEASE | PROSPECTIVE COHORTS | LOW-DENSITY LIPOPROTEIN | NONVASCULAR MORTALITY | MENDELIAN RANDOMIZATION | VASCULAR-DISEASE | Blood Pressure | Diabetes Mellitus - blood | Cholesterol - blood | Humans | Middle Aged | Lung Diseases - mortality | Male | Motor Activity | Coronary Disease - mortality | Neoplasms - blood | Lung Diseases - blood | Interleukin-6 - blood | Female | Leukocyte Count | Stroke - mortality | C-Reactive Protein - analysis | Databases, Factual | Body Mass Index | Coronary Disease - blood | Stroke - prevention & control | Risk Assessment | Smoking - blood | Risk Factors | Neoplasms - mortality | Biomarkers - blood | Stroke - blood | Regression Analysis | Coronary Disease - prevention & control | Serum Albumin | Alcohol Drinking - blood | Alcohol Drinking - epidemiology | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Fibrinogen - analysis | Sex Factors | Triglycerides - blood | Proteins | Mortality | Cardiovascular disease | Statistical methods | Blood pressure | Risk factors | Statins | Inflammatory diseases | Meta-analysis | Clinical Medicine | Kirurgisk forskning | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Surgical research | Klinisk medicin | MEDICINE | Kirurgi | Ortopedi | Orthopaedics
Journal Article
Environmental Health Perspectives, ISSN 0091-6765, 7/2007, Volume 115, Issue 7, pp. 1072 - 1080
Background: Numerous studies have found that ambient air pollution has been associated with cardiovascular disease exacerbation. Objectives: Given previous...
Myocardial infarction | Air pollutants | Particulate matter | Environmental health | Air pollution | Inflammation | Smoke | Research | Epidemiology | Blood | Meteorology | CRP | C-reactive protein | Fibrinogen | Inflammations | IL-6 | RATE-VARIABILITY | fibrinogen | myocardial infarction | ELDERLY SUBJECTS | 5 EUROPEAN CITIES | epidemiology | ENVIRONMENTAL SCIENCES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | inflammation | ultrafine particles | CARDIOVASCULAR-DISEASE | MONICA-AUGSBURG | air pollution | DAILY MORTALITY | CORONARY-HEART-DISEASE | PARTICULATE MATTER | Inflammation - chemically induced | Myocardial Infarction - blood | C-Reactive Protein - metabolism | Interleukin-6 - blood | Humans | Fibrinogen - metabolism | Air Pollution | Causes of | Health aspects | Heart attack | Interleukin-6
Myocardial infarction | Air pollutants | Particulate matter | Environmental health | Air pollution | Inflammation | Smoke | Research | Epidemiology | Blood | Meteorology | CRP | C-reactive protein | Fibrinogen | Inflammations | IL-6 | RATE-VARIABILITY | fibrinogen | myocardial infarction | ELDERLY SUBJECTS | 5 EUROPEAN CITIES | epidemiology | ENVIRONMENTAL SCIENCES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | inflammation | ultrafine particles | CARDIOVASCULAR-DISEASE | MONICA-AUGSBURG | air pollution | DAILY MORTALITY | CORONARY-HEART-DISEASE | PARTICULATE MATTER | Inflammation - chemically induced | Myocardial Infarction - blood | C-Reactive Protein - metabolism | Interleukin-6 - blood | Humans | Fibrinogen - metabolism | Air Pollution | Causes of | Health aspects | Heart attack | Interleukin-6
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9733, pp. 2215 - 2222
Summary Background Uncertainties persist about the magnitude of associations of diabetes mellitus and fasting glucose concentration with risk of coronary heart...
Internal Medicine | MORTALITY | WOMEN | ASIA-PACIFIC REGION | THERAPY | TASK-FORCE | ATHEROSCLEROSIS | CARDIOVASCULAR-DISEASES | CORONARY-HEART-DISEASE | UMCG Approved | PATHOPHYSIOLOGY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE | Diabetes Mellitus - blood | Fasting | Blood Glucose - analysis | Humans | Middle Aged | Risk Factors | Coronary Disease - etiology | Male | Diabetes Complications - blood | Stroke - etiology | Adult | Female | Aged | Stroke (Disease) | Complications and side effects | Research | Diabetes | Coronary heart disease | Risk factors | Heart failure | Heart attacks | Risk assessment | Data collection | Cardiovascular disease | Blood pressure | Estimates | Medical and Health Sciences | Medicin och hälsovetenskap
Internal Medicine | MORTALITY | WOMEN | ASIA-PACIFIC REGION | THERAPY | TASK-FORCE | ATHEROSCLEROSIS | CARDIOVASCULAR-DISEASES | CORONARY-HEART-DISEASE | UMCG Approved | PATHOPHYSIOLOGY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE | Diabetes Mellitus - blood | Fasting | Blood Glucose - analysis | Humans | Middle Aged | Risk Factors | Coronary Disease - etiology | Male | Diabetes Complications - blood | Stroke - etiology | Adult | Female | Aged | Stroke (Disease) | Complications and side effects | Research | Diabetes | Coronary heart disease | Risk factors | Heart failure | Heart attacks | Risk assessment | Data collection | Cardiovascular disease | Blood pressure | Estimates | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1205 - 1213
Summary Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6...
Internal Medicine | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | MEDICINE, GENERAL & INTERNAL | INHIBITION | REDUCTION | INFLAMMATION | RISK | LOCI | ASSOCIATION | FIBRINOGEN | TOCILIZUMAB | Coronary Disease - immunology | Coronary Disease - genetics | Receptors, Interleukin-6 - genetics | Gene Frequency | Humans | Risk Factors | Inflammation Mediators - blood | Genetic Variation - genetics | Signal Transduction - genetics | Causality | Care and treatment | Interleukins | Physiological aspects | Genetic aspects | Cellular signal transduction | Research | Cardiovascular diseases | Genetic variation | Cytokine receptors | Development and progression | Risk factors | Interleukin-6 | Studies | Medical research | Cardiovascular disease | Inventors | Womens health | Clinical Medicine | Allmänmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | General Practice
Internal Medicine | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | MEDICINE, GENERAL & INTERNAL | INHIBITION | REDUCTION | INFLAMMATION | RISK | LOCI | ASSOCIATION | FIBRINOGEN | TOCILIZUMAB | Coronary Disease - immunology | Coronary Disease - genetics | Receptors, Interleukin-6 - genetics | Gene Frequency | Humans | Risk Factors | Inflammation Mediators - blood | Genetic Variation - genetics | Signal Transduction - genetics | Causality | Care and treatment | Interleukins | Physiological aspects | Genetic aspects | Cellular signal transduction | Research | Cardiovascular diseases | Genetic variation | Cytokine receptors | Development and progression | Risk factors | Interleukin-6 | Studies | Medical research | Cardiovascular disease | Inventors | Womens health | Clinical Medicine | Allmänmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | General Practice
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 10/2013, Volume 15, Issue 10, pp. 1173 - 1184
Aims To evaluate how recommendations of European guidelines regarding pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in...
heart failure | MRAs | ICD | CRT | ACE inhibitors | beta‐blockers | Heart failure | Beta-blockers | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | CLINICAL CHARACTERISTICS | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | CARDIAC RESYNCHRONIZATION THERAPY | TASK-FORCE | DEVICE THERAPY | EUROBSERVATIONAL RESEARCH-PROGRAM | US HOSPITALS | HF PILOT | OUTCOMES | Guideline Adherence - statistics & numerical data | Europe | Humans | Middle Aged | Defibrillators, Implantable - utilization | Ambulatory Care - standards | Hospitalization - statistics & numerical data | Male | Cardiology - standards | Mineralocorticoid Receptor Antagonists - therapeutic use | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Nitrates - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Practice Guidelines as Topic | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
heart failure | MRAs | ICD | CRT | ACE inhibitors | beta‐blockers | Heart failure | Beta-blockers | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | CLINICAL CHARACTERISTICS | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | CARDIAC RESYNCHRONIZATION THERAPY | TASK-FORCE | DEVICE THERAPY | EUROBSERVATIONAL RESEARCH-PROGRAM | US HOSPITALS | HF PILOT | OUTCOMES | Guideline Adherence - statistics & numerical data | Europe | Humans | Middle Aged | Defibrillators, Implantable - utilization | Ambulatory Care - standards | Hospitalization - statistics & numerical data | Male | Cardiology - standards | Mineralocorticoid Receptor Antagonists - therapeutic use | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Nitrates - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Practice Guidelines as Topic | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article